Urinary Incontinence, Overactive bladder, Urgency urinary incontinence
Conditions
Interventions
Electrotherapy intervention (balanced biphasic pulsed current, transcutaneously applied in 12 sessions, twice a week for 20 minutes) with electrodes positioned at three different locations, 33 volunte
Device
E02.331
Sponsors
Universidade Federal de São Carlos
Universidade Federal de São Carlos
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Women over the age of 18; with urinary urgency, self-reported and confirmed by a score greater than or equal to 8 in the Overactive Bladder - Validated 8 - Question Awareness Tool (OAB-V8)
Exclusion criteria
Exclusion criteria: To present stress urinary incontinence without symptom of urgency; being with urinary tract infection during the collection period; presenting habits of alcoholism, smoking or drug addiction; lesions and altered cutaneous sensitivity in the place where the procedure will be applied; cognitive deficit; treating (medication or physical therapy) for urinary incontinence or overactive bladder; to have any neurological disease; being in the gestational or puerperium period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of urinary urgency episodes (pre-treatment, 6 th and 12 th sessions and follow-up), by structured questions and the questionnaires: Overactive Bladder Awareness Tool (OAB-V8); Incontinence Questionnaire Overactive Bladder (ICIQ-OAB) | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of daytime/nighttime urinary: by structured questions and the questionnaires: Overactive Bladder Awareness Tool (OAB-V8); Incontinence Questionnaire Overactive Bladder (ICIQ-OAB). All evaluations will take place: pre-treatment, in the 6th and 12th sessions and in the follow up;Urinary incontinence severity: by structured questions and the questionnaires: Overactive Bladder Awareness Tool (OAB-V8); Incontinence Questionnaire Overactive Bladder (ICIQ-OAB). This evaluation will take place: pre-treatment, in the 6th and 12th sessions and in the follow up;Use / number of pads: King's Health Questionnaire. This evaluation will take place: pre-treatment, in the 6th and 12th sessions and in the follow up;Quality of life: King’s Health Questionnaire. This evaluation will take place: pre-treatment, in the 6th and 12th sessions and in the follow up;Number of loss episode urinary: by structured questions and the questionnaires: Overactive Bladder Awareness Tool (OAB-V8); Incontinence Questionnaire Overactive Bladder (ICIQ-OAB). This evaluation will take place: pre-treatment, in the 6th and 12th sessions and in the follow up | — |
Countries
Brazil
Contacts
Public ContactJuliana Padilha
Universidade Federal de São Carlos
Outcome results
None listed